Novorapid 100IU/ml Solution for Injection (Insulin Aspart 100IU)

About Novorapid 100IU/ml Penfill 3 ml

Novorapid 100IU/ml Penfill 3 ml is a rapid-acting human insulin analogue for the treatment of diabetes mellitus in both children (above 2 years of age) and adults. The active ingredient in Novorapid 100IU/ml Penfill 3 ml is insulin aspart. Diabetes is a disease where your body does not produce enough insulin to control the level of your blood sugar. Treatment with Novorapid 100IU/ml Penfill 3 ml helps to prevent complications from your diabetes.

When Novorapid 100IU/ml Penfill 3 ml is injected, it is extremely fast-acting and works rapidly to normalise blood sugar levels. It typically begins working after 10-20 minutes and will last for between 3 and 5 hours. Due to this short action, Novorapid 100IU/ml Penfill 3 ml should normally be taken in combination with intermediate-acting or long-acting insulin preparations. Novorapid 100IU/ml Penfill 3 ml works by ensuring rapid and consistent sugar control. Novorapid 100IU/ml Penfill 3 ml is a fast-acting form of insulin that helps lower blood sugar levels after the intake of food. Prevents the risk of having severe complications of diabetes. It stimulates the recovery of sugar in muscle and fat cells and thus suppresses the production of sugar in the liver.

Your doctor will advise you on how to use Novorapid 100IU/ml Penfill 3 ml. It should be administered at least 5-10 minutes before the meal or within 20 minutes after you start having a meal. The common side effects of Novorapid 100IU/ml Penfill 3 ml are hypokalaemia (low potassium), hypoglycaemia (low blood sugar level), local injection site reactions, lipodystrophy (fat deposition under the skin), rash, and pruritus (itch skin) which may occur at the injection site. Most of these side effects of Novorapid 100IU/ml Penfill 3 ml do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Try not to stop taking Novorapid 100IU/ml Penfill 3 ml of your own. Let your doctor know about this, as it may cause withdrawal symptoms. Do not take Novorapid 100IU/ml Penfill 3 ml if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription recreational drugs. Along with Novorapid 100IU/ml Penfill 3 ml, you should take a healthy diet, do regular exercise, and maintain weight as advised by your doctor. Novorapid 100IU/ml Penfill 3 ml is a cold chain medicine, and so it has to be stored in the refrigerator between 2-8 degrees Celsius else its efficiency might get lost. Do not store in the freezer of the fridge.

Uses of Novorapid 100IU/ml Penfill 3 ml

Type 1 diabetes mellitus, Type 2 diabetes mellitus

Medicinal Benefits

Novorapid 100IU/ml Penfill 3 ml works by ensuring rapid and consistent sugar control. Novorapid 100IU/ml Penfill 3 ml is a fast-acting form of insulin that helps lower blood sugar levels after the intake of food. Prevents the risk of having severe complications of diabetes. It stimulates the recovery of sugar in muscle and fat cells and thus suppresses the production of sugar in the liver. Novorapid 100IU/ml Penfill 3 ml helps in improving the glycaemic control which in turn decreases the risk of progression of complications of diabetes like damage of retina (retinopathy), damage of kidney (nephropathy), damage of nerve cells (neuropathy), delayed wound healing, diabetic foot ulcer and others. Besides this, Novorapid 100IU/ml Penfill 3 ml can be safely prescribed to the diabetic mother in the pregnancy as well as lactation stage.

Directions for Use

Novorapid 100IU/ml Penfill 3 ml is administered 5-10 minutes before taking meal subcutaneously (SC) in the abdomen or thigh region. It can be also given intravenously (IV) with 0.9% sodium chloride infusion. However subcutaneous injection of Novorapid 100IU/ml Penfill 3 ml in the abdomen region ensures faster absorption compared to other injection sites. Novorapid 100IU/ml Penfill 3 ml is usually given once or twice daily when both rapid and prolonged effect of insulin is desired. In the initial requirement, the dose requirement is usually between 0.3 and 1.0 IU/kg per day. An injection of Novorapid 100IU/ml Penfill 3 ml should be followed within 30 minutes by a meal or snack containing sugar/glucose (carbohydrates). If you are not well trained to self-administer Novorapid 100IU/ml Penfill 3 ml, ask healthcare professional to administer it.Procedure for self-injecting insulin:•You should wash your hand first before injecting insulin.•Then roll the insulin bottle and wipe the bottle top.•Now pull the plunger of the syringe down to an appropriate number of units your doctor has prescribed.•Push the needle into the bottle and push syringe plunger down.•Now once again pull the plunger down to an appropriate number of units as prescribed by the doctor.•Pick the injection site and wipe it with an alcohol swab. Now, pinch up the skin and push the needle into the skin and then push the plunger in.•The needle should be kept under the skin for at least 6 seconds to make sure the entire dose is injected.•After injecting the insulin pull out the needle and dispose of the syringe safely. And then you can have a meal or snack.

Side Effects of Novorapid 100IU/ml Penfill 3 ml

Like all medicines, Novorapid 100IU/ml Penfill 3 ml can cause side effects, although not everybody gets them. Common side effects of Novorapid 100IU/ml Penfill 3 ml include hypokalaemia (low potassium), hypoglycaemia (low blood sugar level), local injection site reactions, lipodystrophy (fat deposition under the skin), rash, and pruritus (itchy skin). Severe hypoglycaemia can lead to unconsciousness and may result in temporary or permanent impairment of brain function or even death. It is not necessary for everyone to experience the above side effects. Please consult your doctor immediately if you experience worsening of any of the side-effects.

In-Depth Precautions and Warning

Drug Warnings

Novorapid 100IU/ml Penfill 3 ml is for subcutaneous (under the skin) use only and should never be administered intravenously (IV) or in the veins. If you are changing the brand of insulin or if you need to inject your insulin by another method, it should be done under strict medical supervision. Cases of heart failure have been reported when pioglitazone was used with insulin, especially in patients who are at high risk of cardiac heart failure. The first symptoms of hyperglycaemia (high blood sugar level) may include symptoms like excessive thirst, dry mouth, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, loss of appetite and acetone odour of the breath.

You should closely monitor these symptoms. Symptoms like heart failure, weight gain and oedema (fluid deposition in tissue) should not be overruled. It is advisable not to consume alcohol as it may either increase or decrease your blood glucose level. Care should be taken while travelling across more than two time zones. Your doctor may adjust your insulin schedule. Novorapid 100IU/ml Penfill 3 ml may decrease the level of potassium, leading to a state of hypokalaemia that, if left untreated, may lead to respiratory paralysis, irregular heartbeat rhythm, coma and even death. Do not take Novorapid 100IU/ml Penfill 3 ml if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription recreational drugs.

Drug Interactions

Drug-Drug Interaction: Novorapid 100IU/ml Penfill 3 ml may have an interaction with drugs that may increase the risk of antiarrhythmic (disopyramide), hemorrheologic agents (pentoxifylline), antidiabetic (pramlintide), bleeding disorder drugs (octreotide), antipsychotic (propoxyphene, phenothiazines), female sex hormones (progestogen, oestrogen), thyroid hormones (levothyroxine), anti-asthmatics (albuterol, epinephrine, terbutaline), an antidepressant (fluoxetine, lithium), lipid-lowering pills (reserpine, niacin, clonidine, fenofibrate, guanethidine), pain killers (aspirin), antibiotics (isoniazid), blood sugar enhancing pills (glucagon), male hormone testosterone analogue (danazol), antibiotic (pentamidine).

Drug-Food Interaction: Novorapid 100IU/ml Penfill 3 ml may interact with an ayurvedic, homoeopathy, unani, herbal supplements or OTC items. Tell your doctor if you are using these products. Try to avoid intake of alcoholic beverages with Novorapid 100IU/ml Penfill 3 ml as it may increase or decrease your blood sugar level.

Drug-Disease Interaction: Novorapid 100IU/ml Penfill 3 ml should not be given to patients with kidney disease, liver disease, low blood sugar/glucose level (hypoglycaemia), and low potassium level (hypokalaemia).